SCHEMBL12366104

SCHEMBL12366104

[C-]#[N+]CC(=O)NCCc1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 2/20 0.55
HDAC1 Q13547 2/20 0.55
HDAC2 Q92769 2/20 0.55
HDAC10 Q969S8 2/20 0.55
HDAC11 Q96DB2 2/20 0.55
HDAC8 Q9BY41 2/20 0.55
HDAC6 Q9UBN7 2/20 0.55
NCOR2 Q9Y618 2/20 0.55
HDAC4 P56524 1/20 0.55
HDAC9 Q9UKV0 1/20 0.55
CA12 O43570 2/20 0.54
CA2 P00918 2/20 0.54
CA9 Q16790 2/20 0.54
L3MBTL1 Q9Y468 1/20 0.53
EPHX1 P07099 1/20 0.53
PLAAT5 Q96KN8 1/20 0.51
PLAAT4 Q9UL19 1/20 0.51
CA1 P00915 1/20 0.51
MMP1 P03956 1/20 0.51
MMP2 P08253 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12366109 0.90 L3MBTL1 (0.68) L3MBTL1EPHX1GAAHPGDTAAR1
SCHEMBL11591975 0.82 GAA (0.59) L3MBTL1GAAHPGDEPHX2CYP2C19
SCHEMBL1329289 0.80 HDAC2 (0.60) HDAC3HDAC1HDAC2HDAC10HDAC11
SCHEMBL7765076 0.80 L3MBTL1 (0.79) HDAC3HDAC1HDAC2HDAC10HDAC11
SCHEMBL770890 0.79 TAAR1 (0.73) HDAC3HDAC1HDAC2HDAC10HDAC11
SCHEMBL11186772 0.78 HDAC3 (0.62) HDAC3HDAC1HDAC2HDAC10HDAC11
SCHEMBL696928 0.78 HDAC3 (0.62) HDAC3HDAC1HDAC2HDAC10HDAC11
SCHEMBL2186352 0.78 HDAC2 (0.72) HDAC3HDAC1HDAC2HDAC10HDAC11
SCHEMBL13619739 0.78 HDAC3 (0.62) HDAC3HDAC1HDAC2HDAC10HDAC11
SCHEMBL4153733 0.78 HPGD (0.79) HDAC3HDAC1HDAC2HDAC10HDAC11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7998986-B2 Heterocyclic compounds, in particular N-substituted pyridones for modulating the activity of nuclear receptors EXELIXIS PATENT COMPANY LLC (US) 2011-08-16 US disclosed